tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market
DNLI
Denali Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Denali Therapeutics (DNLI) Stock News & Sentiment

Compare
673 Followers
Denali Therapeutics Begins BLA Submission for Tividenofusp Alfa
Premium
Company Announcements
Denali Therapeutics Begins BLA Submission for Tividenofusp Alfa
4d ago
8K
DNLI
Denali Therapeutics: Promising Growth Prospects Despite Recent Setbacks
Premium
Ratings
Denali Therapeutics: Promising Growth Prospects Despite Recent Setbacks
1M ago
DNLI
Denali Therapeutics Discontinues DNL343 ALS Trial
Premium
Company Announcements
Denali Therapeutics Discontinues DNL343 ALS Trial
1M ago
8K
DNLI
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
Premium
Ratings
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
1M ago
DNLI
Positive Outlook for Denali Therapeutics: Strategic Progress and Promising Developments Support Buy Rating
Premium
Ratings
Positive Outlook for Denali Therapeutics: Strategic Progress and Promising Developments Support Buy Rating
1M ago
DNLI
Denali Therapeutics: Promising ETV Platform and Strategic Advancements Justify Buy Rating
Premium
Ratings
Denali Therapeutics: Promising ETV Platform and Strategic Advancements Justify Buy Rating
1M ago
DNLI
Denali Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
Denali Therapeutics Reports 2024 Financial Results and Progress
1M ago
DNLI
More DNLI News >

DNLI News on the Web

DNLI Begins Rolling BLA Submission for Hunter Syndrome Drug, Stock Up
Zacks
Bullish
Why You Shouldn't Bet Against Denali (DNLI) Stock
Zacks
Neutral
Denali Q4 Earnings Beat Estimates, Hunter Syndrome Drug in Focus
Yahoo Finance
Neutral
Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Yahoo Finance
Neutral
Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome with Tividenofusp Alfa
Yahoo Finance
Neutral
Denali Therapeutics Announces Upcoming Presentations on Hunter Syndrome and TransportVehicle™ Enabled Investigational Therapeutic Tividenofusp Alfa at the 2025 WORLDSymposium™
Yahoo Finance
Neutral
Amgen Set to Report Q4 Earnings: Is a Beat in the Cards?
Zacks
Neutral
Denali Therapeutics: Strategic Advancements and Promising Pipeline Drive Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DNLI
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DNLI’s Media Buzz Sentiment?
1 articles about DNLI were published this week. In an average week, 1 articles are published.
    What is DNLI’s weekly average amount of articles?
    In an average week, 1 articles about DNLI are published.
      What is DNLI’s News Sentiment?
      100% of articles about DNLI were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        GRIGRI Bio
        SLPSimulations Plus
        CORTCorcept Therapeutics
        AMSAmerican Shared Hospital Services
        LFCRLifecore Biomedical
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing